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Background: Childhood onset of anxiety disorders is associated with greater functional impairment and burden
across the lifespan. Recent work suggests that generalized anxiety disorder (GAD) is characterized by dysfunctional
connectivity in amygdala-based circuits at rest in adolescents, consistent with adults. However, neural mechanisms
underlying a broad spectrum of often-comorbid anxiety disorders in children remains unclear and understudied.
The current study examines amygdala functional connectivity at rest in children and adolescents across comorbid
anxiety disorders (ADs) including youth with primary diagnoses of GAD and social phobia (SP).
Results: Compared with healthy controls (HCs), AD youth exhibited hyperconnectivity between the right amygdala
and the insula and hypoconnectivity between the left amygdala and the ventromedial prefrontal cortex (vmPFC)
and posterior cingulate cortex (PCC). Within the AD group, connectivity was not correlated with anxiety severity
and only the amygdala-PCC connectivity was positively correlated with age.
Conclusions: Our findings indicate that youth with comorbid ADs demonstrate aberrant connectivity in the
anterior limbic network (ALN) as well as the PCC at rest. This extends upon previous work suggesting alterations in
amygdala circuits underlying fear learning, emotion regulation, and the processing of interoceptive states. Presence
of these findings within this young, comorbid sample points to underlying common mechanisms across ADs and
illuminates future targets for prevention and intervention in childhood.
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Anxiety disorders (ADs) are among the most prevalent
and disabling psychiatric disorders to occur in youth
[1-4] and set children on a negative trajectory towards
continued and additional comorbid psychological disorders
during adulthood [5-7]. When left untreated, pediatric
anxiety disorders can result in severe ongoing social
impairment, decreased educational achievement, and
interrupted employment [7-9]. The three most common
anxiety disorders among youth include generalized anxiety
disorder (GAD), social phobia (SP), and separation anxiety
disorder (SAD) and are collectively referred to as the
“pediatric anxiety triad” [10,11]. High rates of comorbidity
across these diagnoses suggest greater similarities than* Correspondence: klphan@uic.edu
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unless otherwise stated.differences [12], including sensitivity to perceived or actual
negative life events [13] and debilitating worry leading to
avoidance patterns (DSM-5, 2013). Additionally, these
three disorders respond to similar treatments [12,14,15],
further implicating diagnostic overlap and, perhaps,
common neural mechanisms. Recent examinations of
pediatric anxiety have moved towards a more dimensional
approach by including children with comorbid ADs to
evaluate neural correlates [16], as well as the effectiveness
of treatments, such as cognitive behavioral therapy (CBT),
in reducing the severity of anxiety symptoms [17].
Despite the prevalence and negative sequelae of the
pediatric anxiety triad, research examining the underlying
neural mechanisms is in its infancy. The amygdala is the
most frequently studied region of interest in pediatric
anxiety, given the robust human neuroimaging literature
documenting amygdala activity and connectivity as it
relates to emotional processing and regulation [18,19].
Indeed, amygdala hyperactivation to perceived threat is aThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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disorders [20-22] and frontal regions are known to
have dense bidirectional structural connections with
the amygdala [23,24]. The amygdala is one region
contributing to what has been labeled the anterior
limbic network (ALN; [18]). This network encompasses
connections between the amygdala, medial prefrontal
cortex (mPFC), insula, anterior cingulate cortex (ACC), as
well as the ventrolateral and dorsolateral prefrontal cortexes
(vlPFC, dlPFC) [18]. These regions modulate complex
social and emotional behaviors and share architectural and
functional features [25]. Reciprocal connections within this
network are hypothesized to contribute to monitoring
of internal and external sensory information in order
to maintain emotional equilibrium [26].
The strongest evidence implicating aberrant ALN
function in anxiety disorders derives from several
task-based fMRI studies that measure connectivity of
networks during emotional tasks. Altered functional
connectivity patterns have been observed during emotional
processing and fear responding in regions composing the
ALN among adults with anxiety [27,28] as well as among
youth [19,22,29,30]. Adults with ADs have demonstrated
decreased connectivity between the amygdala and the
rostral ACC and dlPFC while viewing fearful faces [27].
An examination of functional connectivity during a
face-emotion rating task found greater connectivity
between the right amygdala and the insula in youth
with GAD compared to healthy controls (HCs). Anxiety
symptom severity (as measured by the Pediatric Anxiety
Rating Scale (PARS)) was correlated with extent of with
amygdala-insula connectivity [29]. Functional connectivity
studies of both adults and youth support the notion that
ALN disruption contributes to symptoms of anxiety.
Disruptions in this network may underlie core phenotypic
features of the disorder across the lifespan [31].
Functional connectivity can also be measured during
the resting state (labeled rs-fMRI) and allows for the
examination of the intrinsic functional connectivity (iFC)
in the absence of a specific emotional task. Rs-fMRI has
proven useful in interrogating neural circuits implicated
in anxiety-related processes, with several studies
demonstrating the existence of disrupted connectivity
at baseline in amygdala-based networks among adults
with anxiety disorders [27,32]. Importantly, iFC methods
have yielded reliable individual differences in neural
connectivity that are correlated with self-report of behavior
and symptoms [33-36]. This technique has been utilized in
recent studies of healthy adults to demonstrate several iFC
patterns that covaried with positive and negative affect
[35], and trait levels of anxiety modulated amygdala-mPFC
connectivity [37]. These results implicate the relevance of
functional connectivity in the affective domain even in the
absence of an emotional challenge among adults withanxiety disorders. In addition, recent rs-fMRI studies have
demonstrated altered resting state connectivity in regions
considered part of the ALN, including the ACC, mPFC,
and insula [27,38,39].
A region outside of the ALN that has been implicated
in social and general anxiety is the posterior cingulate
cortex (PCC) and the adjacent precuneus. The PCC in
particular may play a role in emotional evaluation [40]
and social behavior [41]. The PCC may also contribute
to modulation of the amygdala [42]. Rs-fMRI data
collected from adults with anxiety disorders found
that reduced connectivity between the amygdala and
the PCC/precuneus was associated with higher state
anxiety [43]. Among adolescents with GAD, one study
that has examined connectivity of the amygdala during a
task of emotional and neutral images found altered
connectivity between the right amygdala and the posterior
cingulate [19]. In sum, task-based fMRI studies have
identified abnormalities in the PCC among youth with
anxiety disorders [19,29], but limited work has examined
this region at rest among youth.
Examinations of connectivity among youth with anxiety
disorders is understudied to date, partly due to the difficulty
in recruiting this population and acclimatizing them to the
fMRI environment. However, the altered connectivity
patterns observed among adults may not be applicable to
pediatric populations due to the important structural and
functional developmental changes known to occur in
the brain during childhood and adolescence [44-46].
Examining the developmental trajectory of neural network
abnormalities among youth with anxiety may elucidate
predictive or modifiable biomarkers of anxiety in addition
to illustrating the long-term effects of anxiety on neurode-
velopment [47]. To the best of our knowledge, only one
study to date has used rs-fMRI to examine functional con-
nectivity in youth with anxiety [48]. This study documented
perturbations in connectivity between the amygdala and
the following regions: ACC, striatum, insula, superior
temporal gyrus, as well as prefrontal regions including
the ventromedial prefrontal cortex (vmPFC), dmPFC,
vlPFC, and dlPFC among fifteen youth between 12 and 17
with a diagnosis of GAD. These differences support a
more widespread disruption of network function than
previously identified.
In the present study, we sought to contribute to the
literature by examining rs-fMRI using bilateral amygdala
seeds in a sample of 33 youth with primary ADs of
GAD and/or SP with several comorbidity profiles and
compared them to data for 23 healthy controls (ages 7 to
19). We chose to examine both the left and right amygdala
seeds separately given the only pediatric anxiety rs-fMRI
study to date detected laterality in amygdala connectivity
[48]. We sought to study a representative heterogeneous
diagnostic group that would allow for greater generalizability
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tion trials that demonstrate comorbidity across these
disorders and commonality in treatment response [14,49].
In line with emotion regulation models of ADs [50], we
hypothesized that relative to healthy peers, youth with
ADs would demonstrate hyperconnectivity between the
amygdala and insula. We also hypothesized that youth
with AD would demonstrate hypoconnectivity between
the amygdala and regions included in the ALN such
as the ACC and mPFC. We also sought to explore
amygdala-PCC connectivity but did not hypothesize a
direction based on the paucity of findings to date.
Methods
Subjects
Participants included 33 children (mean age 13.9 ± 3.1 years;
22 female) with a DSM-IV (1) primary diagnosis of GAD,
SP, and SAD (collectively referred to as ADs) who were
compared to 23 matched HCs (14.6 ± 3.9 years; 13 female;
Table 1). All participants were medication-free at the time
of testing and were recruited from the University of
Michigan Pediatric Anxiety Disorders Clinic as well
as advertisements posted in the local community. All
subjects had negative urine drug test (and pregnancy
test for females) which were administered immediately
prior to the fMRI scan. Exclusion criteria included an
IQ below 70, a lifetime diagnosis of bipolar disorder,
schizophrenia, and/or a pervasive developmental disorder.
Healthy comparison youth were required to be free of
lifetime diagnoses of DSM-IV Axis I and II disorders.
All participants provided written informed consent/assent.
The study was approved by the University of Michigan
Institutional Review Board.
Both groups of participants (HCs and ADs) were inter-
viewed by clinically trained mental health professionals
using the Kiddie-Schedule for Affective Disorders-Present
and Lifetime Version (K-SADS-PL) [51], and diagnosesTable 1 Sample demographic data and clinical features
Anxiety
disorder
Healthy controls p value
Total (n) 33 23
Sex, female, n (%) 22 (67) 13 (57)
Age, mean ± SD 13.9 ± 3.1 14.6 ± 3.9 n.s.
Race 29 C, 2 AA,
2 multi








Social phobia 10 (30%)
PARS ± SD 22 ± 3.9 2 ± 2.5 p < 0.001
C Caucasian, AA African-American, As Asian, Multi multiracial, PARS Pediatric
Anxiety Rating Scale, n.s. non-significant (p > 0.05).were confirmed by a board-certified psychiatrist. A second
rater conducted reliability on 20% of cases to establish
inter-rater reliability. Within the primary GAD group, 10
participants (30%) received a comorbid SP/SAD diagnosis.
Within the primary SP group, 6 participants (40%) received
a comorbid GAD/SAD diagnosis. Current anxiety symptom
severity and impairment was assessed by a clinician
using the PARS [52] which has demonstrated high
inter-rater reliability (The Research Units On Pediatric
Psychopharmacology Anxiety Study Group, 2002).
fMRI acquisition
Functional imaging was performed with blood-oxygen-
level-dependent (BOLD) sensitive whole-brain fMRI
on a 3.0 Tesla GE Signa System (General Electric;
Milwaukee, WI) using a four-channel GE Quadrature
sending and receiving head coil. Images were acquired
with 30 axial, 5-mm-thick slices using a standard
T2*-sensitive gradient echo reverse spiral acquisition
sequence (2 s repetition time; 25 ms echo time; 64 × 64
matrix; 24 cm field of view; flip angle 77°; 3.75 × 3.75 ×
5 mm final voxel size). A high-resolution, T1-weighted
volumetric anatomical scan was also acquired in the axial
plane (9 ms repetition time, 1.8 ms echo time; 256 × 256
matrix; 256 mm field of view; flip angle 15°; 124
slices; 1.2 mm slice thickness) at the same position as
the functional images for anatomical localization and
spatial normalization. Resting-state functional imaging
included one 8-min scan during which participants
were instructed to look at a fixation cross and let their
mind wander without falling asleep.
fMRI analysis
Images were preprocessed and analyzed with the CONN:
functional connectivity toolbox (http://www.nitrc.org/
projects/conn), with preprocessing steps implemented in
SPM8 (http://www.fil.ion.ucl.ac.uk/spm/) running on the
MATLAB (Math Works, Natick, MA) platform. Images
were segmented into gray matter, white matter, and
cerebrospinal fluid (CSF) for use during removal of
temporal confounds. Data were then motion corrected,
coregistered with a high resolution T1 image, normalized
to the Montreal Neurological Institute (MNI) space, and
smoothed with an 8-mm Gaussian kernel of full width at
half-maximum. Importantly, patients and healthy controls
did not significantly differ in either total (p = 0.255),
maximum (p = 0.443) or average (p = 0.170) head motion.
Connectivity preprocessing followed the CompCor method
[53] for removal of non-neuronal sources of noise, as
opposed to relying on global signal regression, which
subsequently allows for interpretation of anticorrelations.
Amygdala connectivity maps were generated for each
subject using a seed-driven approach in which the left
and right amygdala were defined by the Automated
Table 2 Group differences in right amygdala functional
connectivity at rest
Region MNI coordinates Volume T value
x y z (mm3)
AD > HC
Pallidum −12 6 0 536 3.67
Superior temporal
cortex
−54 16 −14 536 3.62
Rectus −4 12 −22 624 3.55
Insula −28 20 −24 688 3.34
Brainstem/pons −6 −10 −24 176 3.32
HC > AD
Cerebellum 28 −62 −40 1,512 4.10
Fusiform cortex −38 −48 −18 280 3.13
All listed clusters are significant at p < 0.005 (uncorrected) with a cluster extent
threshold of greater than 20 contiguous voxels.
Areas showing a priori hypothesized group differences italicized.
MNI Montreal Neurological Institute, AD anxiety disorder, HC healthy control.
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Daemon database [54]. The entire BOLD time course was
extracted from the amygdala seeds, and Pearson’s correl-
ation coefficients were calculated between these entire
time courses and the time courses of all other voxels
across the brain and a mean time course across the entire
region of interest. Fisher transformation was used to con-
vert the resulting correlation coefficients into Z-scores
which were then used in second-level general linear model
analyses. Group differences in amygdala connectivity were
examined using two-tailed independent samples t tests.
To determine significance within a priori regions in which
we had a strong hypothesis within both the ALN (mPFC,
ACC, and insula) and PCC given the extant literature, we
restricted our analyses to these relevant regions using
an anatomically derived (AAL atlas) partial brain
mask of the mPFC, ACC, PCC, and insula (search
volume = 131,272 mm3) inclusive of these four anatomical
areas. For each between-group analysis in the right and
left amygdala connectivity, cluster-based significance
thresholding was used to adjust for multiple comparisons
within the search volume. Cluster-based significance
thresholding was determined via simulation using the
ClusterSim utility (10,000 iterations; http://afni.nimh.nih.
gov/pub/dist/doc/program_help/3dClustSim.html). Given
smoothness estimates of the data (11.2 mm× 11.1 mm×
10.0 mm) across our region of interest mask with a volume
of 131.3 cm3, a family-wise error correction at α < 0.05 is
realized with a voxel threshold of p < 0.001 with minimum
cluster size of 44 voxels (352 mm3).
Statistics
For a priori areas showing group differences, we extracted
parameter estimates/beta weights (connectivity values,
arbitrary units) from a 10-mm spherical region of interest
surrounding peak from each subject to illustrate the
direction of effects. To investigate the relationship
between connectivity differences and clinical symptom
severity, PARS scores were correlated with connectivity
values extracted from regions in which significant group
differences were observed. A similar correlational analysis
was conducted with age. To ensure findings did not
differ by primary diagnoses, we used independent
samples t tests to examine whether significant findings
differed based on a primary diagnosis of GAD versus
a primary diagnosis of SP.
Results and discussion
Group differences in right amygdala connectivity
The AD group exhibited hyperconnectivity from the
right amygdala to the left insula (BA 47, Z-score = 3.34,
p < 0.05, corrected), compared to the HC group (Table 2;
Figure 1A). In contrast, the AD group did not exhibit
hypoconnectivity between the right amygdala to any apriori regions of interest, compared with the HC
group. Table 2 also displays group differences in areas
outside of a priori regions for completeness, to obvi-
ate bias and to promote new hypotheses for future
studies.
Group differences in left amygdala connectivity
The AD group exhibited hypoconnectivity between the
left amygdala and the mPFC (BA 10/11, Z-score = 3.18,
p < 0.05, corrected) and the PCC (BA 26, Z-score = 3.69,
p < 0.05, corrected), as compared with the HC group
(Table 3; Figure 1B). In contrast, the AD group did not
exhibit hyperconnectivity between the left amygdala to
any a priori regions of interest, compared with the HC
group (Table 3). Table 3 also displays group differences
in areas outside of a priori regions for completeness, to
obviate bias, and to promote new hypotheses for future
studies.
Amygdala connectivity and correlations with symptom
severity and age
No significant correlations were observed between
seed-cluster connectivity values from the insula,
vmPFC, and PCC with anxiety severity among youth
with ADs (all ps > 0.5). However, when looking across the
entire sample, PARS scores were significantly negatively
correlated with amygdala-PCC (r = −0.37, p < 0.01) and
amygdala-vmPFC (r = −0.37, p < 0.01) connectivity values
and positively correlated with amygdala-insula (r = 0.36,
p < 0.01) connectivity.
In terms of age, the correlation between left amygdala-
PCC connectivity and age was significant (r = 0.48; p < 0.01)
among youth with AD; the correlation was not significant
within the healthy control group. Increasing age was
Figure 1 Between-group whole-brain voxel-wise statistical t map of a priori hypothesized group differences overlaid on a canonical
brain rendering showing: (A) greater right amygdala connectivity to the insula (anxiety disorder (AD) group > healthy control (HC)
group; and (B) decreased amygdala connectivity to the medial prefrontal cortex (mPFC) and posterior cingulate cortex (PCC) (AD <HC).
Statistical t map thresholded at whole-brain voxel-wise (p < 0.005, cluster volume > 352 mm3, representing corrected α < 0.05); color bar represents
statistical t scores. Bar graph shows mean extracted parameter estimate β weights in arbitrary units (±SEM) within each group from 10 mm
spherical region of interest surrounding peak.
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amygdala and the PCC, whereas among younger children
decreased connectivity between these regions was
observed. Of note, even when controlling for age, the
previously identified connectivity differences between
groups remained.
Comorbidity profiles
Our analysis included 10 participants (30% of the AD
group) with a primary diagnosis of SP compared to 70%
with a primary diagnosis of GAD; as such, we examined
for group differences in connectivity between GAD and SP.
The youth with a primary diagnosis of GAD did not differ
from those with a primary diagnosis of SP for connectivitybetween the amygdala and the insula (t(31) = −0.05,
p = 0.96), left PCC (t(31) = −0.74, p = 0.47), or the left
vmPFC (t(31) = 1.47, p = 0.15).
Discussion
Consistent with our hypotheses, the youth with AD
demonstrated aberrant amygdala connectivity with
regions of the ALN including the vmPFC and insula
when compared to HCs. Surprisingly, we did not find
connectivity differences with the ACC but did observe
amygdala-PCC hypoconnectivity among AD compared to
HC youth. Our results replicate previous observations and
extend upon the only study to date that has examined
resting-state iFC in adolescents with AD [48], suggesting
Table 3 Group differences in left amygdala functional connectivity at rest
Region MNI coordinates Volume T value
x y z (mm3)
AD > HC
Cerebellum 6 −64 −46 1,128 4.02
Brainstem–midbrain −4 −32 −2 272 3.40
Precentral cortex −62 −12 40 192 3.38
Cuneus −8 −96 14 440 3.32
Thalamus −18 −24 8 168 3.14
Ventro-lateral prefrontal cortex 56 38 10 192 3.06
HC > AD
Posterior cingulate cortex 10 −40 24 456 3.69
Superior parietal cortex 16 −58 72 832 3.38
Medial prefrontal cortex 6 62 −4 376 3.18
Inferior parietal cortex −36 −80 44 1,424 3.15
All listed clusters significant at p < 0.005 (uncorrected) with a cluster extent threshold of greater than 20 contiguous voxels.
Areas showing a priori hypothesized group differences italicized.
MNI Montreal Neurological Institute, AD anxiety disorder, HC healthy control.
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across diagnostic categories - from GAD to SP and their
comorbidities.
Specifically, we found hyperconnectivity between the
right amygdala seed and the left insula among anxious
youth compared to HC peers, consistent with the previous
literature [34,55-57]. Insula and amygdala involvement in
the detection of salience, emotion, and attention is well
established [34] and task-based fMRI findings have
indicated the hyperactivity of these regions may be a
key neural mechanism underlying anxiety-related processes
[34,58,59]. The amygdala has been found to be structurally
connected to the insula [60], and our results contribute to
emerging evidence of a functional connection between the
structures [27,34,48]. Altered functional connectivity
between the amygdala and insula has been previously
observed in groups with anxiety disorders during task
[27,29] and more recently during rest [27,38,39,48].
Given the insula’s role in interoceptive processing,
increased connectivity with the amygdala at rest may
reflect increased interactions between a region implicated
in fear perception-expression (amygdala) and another
implicated in anxious arousal-anticipation (insula).
The extant literature implicates dysfunction in amygdala
connections to the prefrontal cortex [19]. Our finding of
decreased iFC between the amygdala and frontal regions
such as the vmPFC among youth with ADs is consistent
with prior findings in adult and pediatric resting-state
studies. Specifically, previous research in healthy adults
has demonstrated positive coupling between the amygdala
and vmPFC at rest [37,61] and has also found this
relationship to be compromised in those with higher
levels of self-reported anxiety [37]. The latter study foundthose with high levels of anxiety displayed negative
coupling between the amygdala and vmPFC. These
findings have since been replicated within a sample of
adolescents with GAD [48]. This study documented
perturbed amygdala-PFC circuitry, finding negative
connectivity between amygdala and vmPFC and positive
connectivity between amygdala and dmPFC, in the group of
adolescents with GAD. The healthy control adolescents
showed opposite patterns of coupling between the amygdala
and these regions. Our findings of negative connectivity
between the amygdala and vmPFC within the AD group
contribute to the growing body of evidence implicating
disruption of the dynamic interplay within amygdala-PFC
circuitry among individuals with anxiety disorders. Further,
our results suggest this aberrant connectivity pattern can be
observed at rest. Taken together, these findings suggest
inefficient crosstalk between the amygdala and mPFC
may lead to increased anxiety levels. Additional research
will be needed in order to determine if this compromised
connectivity is a defining feature of the underlying
neurocircuitry of anxiety disorders.
In the current study, we observed altered connectivity
between the amygdala and PCC, which is consistent with
the growing body of literature linking disruption of this
functional connection to mood and anxiety disorders
[42,43,62]. Recent studies have implicated functional
connections between the amygdala and posterior regions,
such as the PCC and precuneus [19,29], in the implemen-
tation of emotional processing [62]. In addition, the PCC
is a hub in the default mode network (DMN), a network
that subserves processes such as mentalization and
self-referential thinking [19,29], which may contribute
to hypervigilance to interoceptive cues of anxiety. Indeed,
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nectivity in pediatric GAD cohorts during emotional pro-
cessing tasks [19,29] and at rest [48]. Taken together, these
convergent findings suggest a tonic (task-independent)
versus phasic (task-dependent) disruption in amygdala-
PCC connectivity and future research will be needed to
elucidate whether this is a defining neural underpinning of
pediatric anxiety disorders. Recent work in depression
has shown that treatment normalizes posterior cingulate-
amygdala connectivity [52] and our findings suggest
treatment targets for ADs and depression may overlap.
Amygdala-based connectivity correlated with PARS
anxiety score across the entire sample, but this correl-
ation was not significant within the AD group or HC
group when considered independently, likely due to re-
striction of range. However, within the AD group, con-
nectivity between the amygdala and PCC was positively
correlated with age. Given this is the first documentation
of this finding among youth and a cross-sectional study,
we hesitate to over-interpret this finding. However,
among HC youth, decreased connectivity between the
amygdala and PCC has been observed across develop-
ment [63]. The PCC is a key node in the DMN and
default mode regions are known to functionally connect
in a more integrated fashion across development [64],
which may contribute to the current finding.
The current study is not without limitation. Although
the sample size represents the largest to date, replication
with a larger cohort of youth is necessary. However, the
comorbidity profile of the current cohort may make our
findings more generalizable, while noting that most patients
(70%) had a GAD diagnosis. Participants in the current
study met criteria for multiple ADs, similar to children pre-
senting in clinical settings for treatment and to more recent
clinical trials testing the efficacy of interventions in redu-
cing overall anxiety. Moreover, although we observed one
finding was significantly correlated with age, our sample
size is underpowered for these analyses within the AD
group. We captured a relatively wide age range in line with
our desire to cast a wider net than previous studies. Data
collection is ongoing, and a larger sample will allow for
greater exploration of potential developmental effects. This
larger sample may also allow for greater variability in anx-
iety levels within the AD group, making it more likely that
variability in network functioning can be linked to severity
of symptoms. We did not collect state anxiety symptoms at
the time of the fMRI scan to relate to resting-state amyg-
dala iFC. An additional limitation of the current data is that
adolescent network functioning may differ from that of
children and we look forward to future studies that can
explore the nuances of healthy and disordered brain devel-
opment. Clearly, the examination of the developmental
trajectories of resting state networks among youth with and
without ADs will be a groundbreaking work. Lastly, this isa cross-sectional observation and emotional face processing
tasks (findings reported elsewhere) administered before
the resting-state scan may have influenced connectivity in
unexpected ways. Future work should address multiple
resting state collection periods, acute influences of a pre-
ceding “emotional” task, as well as test order effects across
tasks and rest, in order to determine the reliability of these
networks.
Conclusions
The current findings indicate that youth with ADs
demonstrate altered intrinsic functional connectivity
patterns, which has several implications. First, these
results suggest dysfunction in the ALN, even in the
absence of a specific anxiogenic task. Second, our results of
aberrant connectivity are consistent with the adult litera-
ture. If network dysfunction is detectable early in the
course of illness across youth with multiple ADs, then this
may be a useful target for existing and novel treatments.
This also opens the possibility that aberrant amygdala-
frontal iFC is present early in the pathophysiology of
pediatric anxiety and thus can serve as a potential
biomarker of risk or illness development. Lastly, the
examination of a brain marker across distinct primary
AD diagnoses takes a step towards new dimensional
construct of developmental psychopathology consistent
with the Research Domain Criteria (RDoC) [65,66].
Abbreviations
GAD: generalized anxiety disorder; AD: anxiety disorder; SP: social phobia;
HC: healthy control; vmPFC: ventromedial prefrontal cortex; PCC: posterior
cingulate cortex; ALN: anterior limbic network; SAD: separation anxiety
disorder; CBT: cognitive behavioral therapy; mPFC: medial prefrontal cortex;
ACC: anterior cingulate cortex; vlPFC: ventrolateral prefrontal cortex;
dlPFC: dorsolateral prefrontal cortex; PARS: Pediatric Anxiety Rating Scale;
rs-fMRI: resting-state functional magnetic resonance imaging; iFC: intrinsic
functional connectivity; BOLD: blood-oxygen-level-dependent;
AAL: automated anatomical labeling; DMN: default mode network.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LH participated in the acquisition, analysis, and interpretation of the data,
along with drafting and revising the manuscript. RJ participated in the
analysis and interpretation of the data, along with drafting and revising the
manuscript. DF participated in the analysis and interpretation of the data,
along with revising the manuscript. MJ participated in the acquisition and
interpretation of the data, along with drafting the manuscript. KF
participated in the conception and design of the study, along with revising
the manuscript. SL participated in the analysis and interpretation of the data
and in the revision of the manuscript. CM participated in the conception and
design of the study, along with revising the manuscript. KLP participated in
the conception and design of the study, along with interpretation of the
data and drafting of the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This study was supported by the National Institutes of Health (R01MH086517
to KLP and CSM). RHJ was supported by the National Institutes of Health
(UL1TR00050). The content is solely the responsibility of the authors and
does not necessarily represent the official views of the National Institutes
of Health.
Hamm et al. Biology of Mood & Anxiety Disorders 2014, 4:15 Page 8 of 9
http://www.biolmoodanxietydisord.com/content/4/1/15Author details
1Department of Psychiatry, University of Illinois at Chicago, 1747 W. Roosevelt
Road, IJR/WROB Rm. 244, Chicago, IL 60608, USA. 2Department of Psychiatry,
University of Michigan, Ann Arbor, Michigan, USA. 3Department of Psychology,
University of Michigan, Ann Arbor, Michigan, USA. 4Department of Psychology,
University of Illinois at Chicago, Chicago, Illinois, USA. 5Department of Anatomy
and Cell Biology, University of Illinois at Chicago, Chicago, Illinois, USA.
Received: 29 August 2014 Accepted: 28 November 2014References
1. Pine DS, Cohen P, Gurley D, Brook J, Ma Y: The risk for early-adulthood
anxiety and depressive disorders in adolescents with anxiety and
depressive disorders. Arch Gen Psychiatry 1998, 55:56–64.
2. Costello EJ, Angold A, Burns BJ, Stangl DK, Tweed DL, Erkanli A, Worthman CM:
The Great Smoky Mountains Study of Youth. Goals, design, methods, and
the prevalence of DSM-III-R disorders. Arch Gen Psychiatry 1996,
53:1129–1136.
3. Beesdo K, Bittner A, Pine DS, Stein MB, Höfler M, Lieb R, Wittchen H-U:
Incidence of social anxiety disorder and the consistent risk for secondary
depression in the first three decades of life. Arch Gen Psychiatry 2007,
64:903–912.
4. Merikangas KR, He J-P, Burstein M, Swanson SA, Avenevoli S, Cui L, Benjet C,
Georgiades K, Swendsen J: Lifetime prevalence of mental disorders in U.S.
adolescents: results from the National Comorbidity Survey Replication–
Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 2010,
49:980–989.
5. Labellarte MJ, Ginsburg GS, Walkup JT, Riddle MA: The treatment of
anxiety disorders in children and adolescents. Biol Psychiatry 1999,
46:1567–1578.
6. Stein MB: Disability and quality of life in social phobia: epidemiologic
findings. Am J Psychiatry 2000, 157:1606–1613.
7. Safren SA, Heimberg RG, Brown EJ, Holle C: Quality of life in social phobia.
Depress Anxiety 1996, 4:126–133.
8. Hambrick JP, Turk CL, Heimberg RG, Schneier FR, Liebowitz MR: The
experience of disability and quality of life in social anxiety disorder.
Depress Anxiety 2003, 18:46–50.
9. Safren SA, Heimberg RG, Juster HR: Clients’ expectancies and their
relationship to pretreatment symptomatology and outcome of
cognitive-behavioral group treatment for social phobia. J Consult Clin Psychol
1997, 65:694–698.
10. Beesdo K, Pine DS, Lieb R, Wittchen H-U: Incidence and risk patterns of
anxiety and depressive disorders and categorization of generalized
anxiety disorder. Arch Gen Psychiatry 2010, 67:47–57.
11. Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Green JG, Gruber MJ, He
J, Koretz D, McLaughlin KA, Petukhova M, Sampson NA, Zaslavsky AM,
Merikangas KR: Prevalence, persistence, and sociodemographic correlates
of DSM-IV disorders in the National Comorbidity Survey Replication
Adolescent Supplement. Arch Gen Psychiatry 2012, 69:372–380.
12. Verduin TL, Kendall PC: Differential occurrence of comorbidity within
childhood anxiety disorders. J Clin Child Adolesc Psychol 2003, 32:290–295.
13. Silverman WK, Ollendick TH: Evidence-based assessment of anxiety and its
disorders in children and adolescents. J Clin Child Adolesc Psychol 2005,
34:380–411.
14. Compton SN, Walkup JT, Albano AM, Piacentini JC, Birmaher B, Sherrill JT,
Ginsburg GS, Rynn MA, McCracken JT, Waslick BD, Iyengar S, Kendall PC,
March JS: Child/Adolescent Anxiety Multimodal Study (CAMS): rationale,
design, and methods. Child Adolesc Psychiatry Ment Health 2010, 4:1.
15. Kendall PC, Compton SN, Walkup JT, Birmaher B, Albano AM, Sherrill J,
Ginsburg G, Rynn M, McCracken J, Gosch E, Keeton C, Bergman L, Sakolsky
D, Suveg C, Iyengar S, March J, Piacentini J: Clinical characteristics of
anxiety disordered youth. J Anxiety Disord 2010, 24:360–365.
16. Van den Bulk BG, Meens PHF, van Lang NDJ, de Voogd EL, van der Wee NJA,
Rombouts SARB, Crone EA, Vermeiren RRJM: Amygdala activation during
emotional face processing in adolescents with affective disorders: the role
of underlying depression and anxiety symptoms. Front Hum Neurosci 2014,
8:393.
17. Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT,
Ginsburg GS, Rynn MA, McCracken J, Waslick B, Iyengar S, March JS,Kendall PC: Cognitive behavioral therapy, sertraline, or a combination in
childhood anxiety. N Engl J Med 2008, 359:2753–2766.
18. Strawn JR, Dominick KC, Doyle CD, Picard LS, Phan KL: Neurobiology of
pediatric anxiety disorders. Curr Behav Neurosci Rep 2014, 1:154–160.
19. Strawn JR, Bitter SM, Weber WA, Chu W-J, Whitsel RM, Adler C, Cerullo MA,
Eliassen J, Strakowski SM, DelBello MP: Neurocircuitry of generalized
anxiety disorder in adolescents: a pilot functional neuroimaging and
functional connectivity study. Depress Anxiety 2012, 29:939–947.
20. Monk CS, Nelson EE, McClure EB, Mogg K, Bradley BP, Leibenluft E, Blair RJR,
Chen G, Charney DS, Ernst M, Pine DS: Ventrolateral prefrontal cortex
activation and attentional bias in response to angry faces in adolescents
with generalized anxiety disorder. Am J Psychiatry 2006, 163:1091–1097.
21. Beesdo K, Lau JYF, Guyer AE, McClure-Tone EB, Monk CS, Nelson EE, Fromm SJ,
Goldwin MA, Wittchen H-U, Leibenluft E, Ernst M, Pine DS: Common and
distinct amygdala-function perturbations in depressed vs anxious
adolescents. Arch Gen Psychiatry 2009, 66:275–285.
22. Guyer AE, Lau JYF, McClure-Tone EB, Parrish J, Shiffrin ND, Reynolds RC, Chen G,
Blair RJR, Leibenluft E, Fox NA, Ernst M, Pine DS, Nelson EE: Amygdala and
ventrolateral prefrontal cortex function during anticipated peer evaluation in
pediatric social anxiety. Arch Gen Psychiatry 2008, 65:1303–1312.
23. Ghashghaei HT, Hilgetag CC, Barbas H: Sequence of information
processing for emotions based on the anatomic dialogue between
prefrontal cortex and amygdala. Neuroimage 2007, 34:905–923.
24. Petrides M, Pandya D: Association pathways of the prefrontal cortex and
functional observations. In Princ Front Lobe Funct. Oxford: Oxford University
Press; 2002:31–50.
25. Cerullo MA, Adler CM, Delbello MP, Strakowski SM: The functional
neuroanatomy of bipolar disorder. Int Rev Psychiatry 2009, 21:314–322.
26. Strakowski SM, Eliassen JC, Lamy M, Cerullo MA, Allendorfer JB, Madore M,
Lee J-H, Welge JA, DelBello MP, Fleck DE, Adler CM: Functional magnetic
resonance imaging brain activation in bipolar mania: evidence for
disruption of the ventrolateral prefrontal-amygdala emotional pathway.
Biol Psychiatry 2011, 69:381–388.
27. Prater KE, Hosanagar A, Klumpp H, Angstadt M, Phan KL: Aberrant
amygdala–frontal cortex connectivity during perception of fearful faces
and at rest in generalized social anxiety disorder. Depress Anxiety 2013,
30:234–241.
28. Etkin A, Prater KE, Hoeft F, Menon V, Schatzberg AF: Failure of anterior
cingulate activation and connectivity with the amygdala during implicit
regulation of emotional processing in generalized anxiety disorder.
Am J Psychiatry 2010, 167:545–554.
29. McClure EB, Monk CS, Nelson EE, Parrish JM, Adler A, Blair RJR, Fromm S,
Charney DS, Leibenluft E, Ernst M, Pine DS: Abnormal attention
modulation of fear circuit function in pediatric generalized anxiety
disorder. Arch Gen Psychiatry 2007, 64:97–106.
30. Monk CS, Telzer EH, Mogg K, Bradley BP, Mai X, Louro HMC, Chen G,
McClure-Tone EB, Ernst M, Pine DS: Amygdala and ventrolateral prefrontal
cortex activation to masked angry faces in children and adolescents with
generalized anxiety disorder. Arch Gen Psychiatry 2008, 65:568–576.
31. Casey BJ, Ruberry EJ, Libby V, Glatt CE, Hare T, Soliman F, Duhoux S,
Frielingsdorf H, Tottenham N: Transitional and translational studies of risk
for anxiety. Depress Anxiety 2011, 28:18–28.
32. Etkin A, Prater KE, Schatzberg AF, Menon V, Greicius MD: Disrupted
amygdalar subregion functional connectivity and evidence of a
compensatory network in generalized anxiety disorder. Arch Gen Psychiatry
2009, 66:1361–1372.
33. Bijsterbosch J, Smith S, Forster S, John OP, Bishop SJ: Resting state
correlates of subdimensions of anxious affect. J Cogn Neurosci 2014,
26:914–926.
34. Baur V, Hänggi J, Langer N, Jäncke L: Resting-state functional and
structural connectivity within an insula-amygdala route specifically index
state and trait anxiety. Biol Psychiatry 2013, 73:85–92.
35. Rohr CS, Okon-Singer H, Craddock RC, Villringer A, Margulies DS: Affect and
the brain’s functional organization: a resting-state connectivity approach.
PLoS One 2013, 8:e68015.
36. Li Y, Qin W, Jiang T, Zhang Y, Yu C: Sex-dependent correlations between the
personality dimension of harm avoidance and the resting-state functional
connectivity of amygdala subregions. PLoS One 2012, 7:e35925.
37. Kim MJ, Gee DG, Loucks RA, Davis FC, Whalen PJ: Anxiety dissociates
dorsal and ventral medial prefrontal cortex functional connectivity with
the amygdala at rest. Cereb Cortex 2011, 21:1667–1673.
Hamm et al. Biology of Mood & Anxiety Disorders 2014, 4:15 Page 9 of 9
http://www.biolmoodanxietydisord.com/content/4/1/1538. Rabinak CA, Angstadt M, Welsh RC, Kenndy AE, Lyubkin M, Martis B,
Phan KL: Altered amygdala resting-state functional connectivity in
post-traumatic stress disorder. Front Psychiatry 2011, 2:62.
39. Sripada RK, King AP, Garfinkel SN, Wang X, Sripada CS, Welsh RC, Liberzon I:
Altered resting-state amygdala functional connectivity in men with
posttraumatic stress disorder. J Psychiatry Neurosci 2012, 37:241–249.
40. Wright P, Albarracin D, Brown RD, Li H, He G, Liu Y: Dissociated responses
in the amygdala and orbitofrontal cortex to bottom-up and top-down
components of emotional evaluation. Neuroimage 2008, 39:894–902.
41. Adolphs R: Cognitive neuroscience of human social behaviour. Nat Rev Neurosci
2003, 4:165–178.
42. Pessoa L, Padmala S, Morland T: Fate of unattended fearful faces in the
amygdala is determined by both attentional resources and cognitive
modulation. Neuroimage 2005, 28:249–255.
43. Hahn A, Stein P, Windischberger C, Weissenbacher A, Spindelegger C,
Moser E, Kasper S, Lanzenberger R: Reduced resting-state functional
connectivity between amygdala and orbitofrontal cortex in social anxiety
disorder. Neuroimage 2011, 56:881–889.
44. Gee DG, Humphreys KL, Flannery J, Goff B, Telzer EH, Shapiro M, Hare TA,
Bookheimer SY, Tottenham N: A developmental shift from positive to
negative connectivity in human amygdala-prefrontal circuitry. J Neurosci
2013, 33:4584–4593.
45. Andreescu C, Sheu LK, Tudorascu D, Walker S, Aizenstein H: The ages of
anxiety–differences across the lifespan in the default mode network
functional connectivity in generalized anxiety disorder. Int J Geriatr Psychiatry
2014, 29:704–712.
46. Perlman SB, Pelphrey KA: Developing connections for affective regulation:
age-related changes in emotional brain connectivity. J Exp Child Psychol
2011, 108:607–620.
47. Qin S, Young CB, Duan X, Chen T, Supekar K, Menon V: Amygdala
subregional structure and intrinsic functional connectivity predicts
individual differences in anxiety during early childhood. Biol Psychiatry
2014, 75:892–900.
48. Roy AK, Fudge JL, Kelly C, Perry JSA, Daniele T, Carlisi C, Benson B,
Xavier Castellanos F, Milham MP, Pine DS, Ernst M: Intrinsic functional
connectivity of amygdala-based networks in adolescent generalized
anxiety disorder. J Am Acad Child Adolesc Psychiatry 2013, 52:290–299. e2.
49. Salum GA, Desousa DA, do Rosário MC, Pine DS, Manfro GG: Pediatric
anxiety disorders: from neuroscience to evidence-based clinical practice.
Rev Bras Psiquiatr 2013, 35(Suppl 1):S03–S21.
50. Mennin DS, Heimberg RG, Turk CL, Fresco DM: Preliminary evidence for an
emotion dysregulation model of generalized anxiety disorder. Behav Res Ther
2005, 43:1281–1310.
51. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D,
Ryan N: Schedule for Affective Disorders and Schizophrenia for School-Age
Children-Present and Lifetime Version (K-SADS-PL): initial reliability and
validity data. J Am Acad Child Adolesc Psychiatry 1997, 36:980–988.
52. Research Units on Pediatric Psychopharmacology Anxiety Study Group,
(RUPP): The Pediatric Anxiety Rating Scale (PARS): development and
psychometric properties. J Am Acad Child Adolesc Psychiatry 2002,
41:1061–1069.
53. Behzadi Y, Restom K, Liau J, Liu TT: A component based noise correction
method (CompCor) for BOLD and perfusion based fMRI. Neuroimage 2007,
37:90–101.
54. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O,
Delcroix N, Mazoyer B, Joliot M: Automated anatomical labeling of
activations in SPM using a macroscopic anatomical parcellation of the
MNI MRI single-subject brain. Neuroimage 2002, 15:273–289.
55. LeDoux JE: Emotion: clues from the brain. Annu Rev Psychol 1995,
46:209–235.
56. Menon V, Uddin LQ: Saliency, switching, attention and control: a network
model of insula function. Brain Struct Funct 2010, 214:655–667.
57. Craig ADB: How do you feel–now? The anterior insula and human
awareness. Nat Rev Neurosci 2009, 10:59–70.
58. Etkin A, Wager TD: Functional neuroimaging of anxiety: a meta-analysis
of emotional processing in PTSD, social anxiety disorder, and specific
phobia. Am J Psychiatry 2007, 164:1476–1488.
59. Etkin A: Functional neuroanatomy of anxiety: a neural circuit perspective.
Curr Top Behav Neurosci 2010, 2:251–277.60. Reynolds SM, Zahm DS: Specificity in the projections of prefrontal and
insular cortex to ventral striatopallidum and the extended amygdala.
J Neurosci 2005, 25:11757–11767.
61. Roy AK, Shehzad Z, Margulies DS, Kelly AMC, Uddin LQ, Gotimer K, Biswal BB,
Castellanos FX, Milham MP: Functional connectivity of the human amygdala
using resting state fMRI. Neuro Image 2009, 45:614–626.
62. Fang Z, Zhu S, Gillihan SJ, Korczykowski M, Detre JA, Rao H: Serotonin
transporter genotype modulates functional connectivity between
amygdala and PCC/PCu during mood recovery. Front Hum Neurosci
2013, 7:704.
63. Gabard-Durnam LJ, Flannery J, Goff B, Gee DG, Humphreys KL, Telzer E,
Hare T, Tottenham N: The development of human amygdala functional
connectivity at rest from 4 to 23 years: a cross-sectional study.
Neuroimage 2014, 95:193–207.
64. Fair DA, Cohen AL, Dosenbach NUF, Church JA, Miezin FM, Barch DM,
Raichle ME, Petersen SE, Schlaggar BL: The maturing architecture of the
brain’s default network. Proc Natl Acad Sci U S A 2008, 105:4028–4032.
65. Cuthbert BN, Kozak MJ: Constructing constructs for psychopathology: the
NIMH research domain criteria. J Abnorm Psychol 2013, 122:928–937.
66. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C,
Wang P: Research domain criteria (RDoC): toward a new classification
framework for research on mental disorders. Am J Psychiatry 2010,
167:748–751.
doi:10.1186/s13587-014-0015-4
Cite this article as: Hamm et al.: Aberrant amygdala functional
connectivity at rest in pediatric anxiety disorders. Biology of Mood &
Anxiety Disorders 2014 4:15.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
